Current Headlines

  1. Bio-Rad Launches PrecisionAb™ Antibodies Validated Specifically for Western Blotting
    6/18/2015

    Stringent Validation and Quality Control Ensure Confidence in Antibodies and Results

  2. ISPE Developing Gap Analysis Tool to Help Ensure an Uninterrupted Supply of Medicines
    6/18/2015

    nternational Society for Pharmaceutical Engineering (ISPE) to announce at its Annual European Conference in Frankfurt, Germany, the development of a tool to aid manufacturers in locating gaps in production and quality systems – an important element in solving of shortages in the international supply of medicines.

  3. Beckman Coulter Diagnostics Showcases The New DxN VERIS Molecular Diagnostics System At The 2015 EuroMedLab
    6/16/2015

    Beckman Coulter Diagnostics is showcasing its revolutionary DxN VERIS Molecular Diagnostics System at Innovations to Improve Workflow for the Diagnostics Laboratory, booth D23 and D24 at the IFCC-EFLM EuroMedLab, 22-24 June 2015, Palais des Congrès, Paris, France.

  4. The Medical Research Network Announces Partnership With World Courier
    6/10/2015

    The Medical Research Network (MRN) has entered into a strategic partnership with World Courier to create a more highly integrated model for community-based clinical trials that increases patient recruitment and retention, using World Courier to ensure the integrity of trial products all the way to the point of patient administration.

  5. Goodwin Biotechnology And Aspyrian Therapeutics Collaborate On The Successful GMP Manufacturing And IND Submission For A Novel Antibody Drug Conjugate (ADC) Platform
    6/9/2015

    Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization (CDMO) that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, has partnered with Aspyrian Therapeutics to successfully complete process development, scale-up, and cGMP manufacturing of their novel Antibody Drug Conjugate (ADC).

  6. Sartorius Opens New Application Center In Bohemia, New York
    6/9/2015

    Sartorius, a leading international laboratory and pharmaceutical equipment supplier, officially opened a new Application Center at its North American headquarters in Bohemia, New York last week.

  7. Paratek Pharmaceuticals Strengthens Senior Leadership Team
    6/4/2015

    Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced the addition of two experienced pharmaceutical executives to the company's senior leadership team to meet the company's growing needs as it advances the development program for its lead investigational antibiotic, omadacycline, and as it expands the company's pre-commercialization capabilities.

  8. Two Clinical Stage Products Lead The Way In A Promising Pipeline – Small Cap IR
    6/3/2015

    According to the World Health Organization, over 14 million new cases of cancer are reported each year and cancer cases are expected to surge 57% worldwide over the next 20 years.

  9. DCAT Announces Sharp Sourcing 2015
    6/2/2015

    The Drug, Chemical & Associated Technologies Association (DCAT) announces DCAT Sharp Sourcing 2015, a conference and networking event for pharmaceutical, biopharmaceutical companies and suppliers in the pharmaceutical manufacturing value chain. 

  10. MGB Biopharma Succeeds In Developing An IV Formulation Of MGB-BP-3 For The Treatment Of Systemic Susceptible And Resistant Gram-Positive Hospital-Acquired Infections
    6/2/2015

    MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, to address the major global problem of antibiotic resistance - announces that it has developed a stable intravenous (IV) formulation of MGB-BP-3, designed for the treatment of systemic susceptible and resistant Gram-positive hospital-acquired infections.

Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.